Last reviewed · How we verify
NCT04154722: [XDRTYPHOID]
Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children
Phase 4 trial testing Meropenem Injection in Typhoid Fever in 126 participants. Completed in 30 December 2020.
30 December 2020
Quick facts
| Lead sponsor | Ziauddin University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 126 |
| Start date | 20 June 2019 |
| Primary completion | 30 December 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Meropenem Injection — full drug profile →
- Azithromycin Powder — full drug profile →
Conditions studied
- Typhoid Fever — all drugs for Typhoid Fever →
Sponsor
Ziauddin University
Who can join
Adults 6 Months to 18, any sex, with Typhoid Fever. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates whether XDR Typhoid fever in children can be effectively treated with monotherapy (meropenum alone), or a combination (meropenum and azithromycin).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04154722
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Meropenem Injection
Trials testing the same drug.
- NCT07314281 — Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever · Phase 4 · recruiting
- NCT06818565 — Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients · NA · not yet recruiting
- NCT05393505 — Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection · Phase 4 · unknown
- NCT04555798 — Effect of Arterio-venous ECMO on Severe Sepsis and ARDS · Phase 1, PHASE2 · completed
- NCT04370145 — Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy · Phase 4 · completed
Other recruiting trials for Typhoid Fever
Currently open trials in the same condition.
- NCT04083950 — Induction of Gut Permeability by an Oral Vaccine · EARLY_PHASE1 · active not recruiting
Other Ziauddin University trials
Trials by the same sponsor.
- NCT07325981 — Effect of Biofeedback-Enhanced Exergaming, Exergaming Alone, and Traditional Physical Therapy on Motor Function, Adheren · NA · not yet recruiting
- NCT06871904 — Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis · Phase 1, PHASE2 · completed
- NCT07097441 — To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With · Phase 1, PHASE2 · completed
- NCT07232316 — Effect of Integrated Neuromuscular Inhibition Technique on Scapular Dyskinesia Type 2 · NA · completed
- NCT07079514 — Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients · Phase 1, PHASE2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04154722 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ziauddin University
- Last refreshed: 16 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04154722.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing